Therapeutics for XXXX .

@entity1 @entity13937 @entity17 @entity308 @entity227 @entity410 @entity912 @entity508 @entity1295 @entity425 @entity12280 @entity400 @entity9 @entity1282 @entity393 @entity15 @entity293 @entity4653
Symptoms management in @entity15 is an integral part of its care. Accurate assessment and addressing the different symptoms provides increased quality of life among @entity1 with @entity15 . @entity12280 may be identified as primary, secondary, or tertiary symptoms. Primary symptoms, such as @entity425 , @entity13937 , are directly related to @entity17 and @entity393 . Secondary symptoms, such as @entity293 as a result of urinary retention, are a result of the primary symptoms. Tertiary symptoms, such as @entity308 or social isolation, are a result of the social and psychological consequences of the disease. Common @entity12280 include @entity1295 and @entity425 ; decreased balance, @entity508 and gait problems; @entity308 and cognitive issues; bladder, bowel, and @entity227 ; and @entity9 . Less-common symptoms include @entity4653 and @entity1282 , vertigo, and @entity400 . Rare symptoms in @entity15 include @entity410 , @entity393 , and @entity912 . Symptom management includes nonpharmacological methods, such as rehabilitation and psychosocial support, and pharmacological methods, ie, medications and surgical procedures. The keys to symptom management are awareness, knowledge, and coordination of care. Symptoms have to be recognized and management needs to be individualized. @entity15 therapeutics include nonpharmacological strategies that consist of lifestyle modifications, rehabilitation, social support, counseling, and pharmacological agents or surgical procedures. The goal is vigilant management to improve quality of life and promote realistic expectations and hope.
